RCUS
Arcus Biosciences Inc
24.50$
+1.0%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | 13,150.3% | 971.7% | 932.2% | 1,095.9% | 299.7% | 732.1% | 888.8% | 1,428.5% | 985.2% | 212.2% | 1,322.4% | 2,039.6% | 80.3% | 513.5% | 701.7% | 726.9% | 753.1% | 0.7% | 19.1% | 13.1% | 10.9% | 10.2% | 16.0% | 13.8% | 9.4% | 16.1% | 2.1% | 5.1% | – | 11.5% | – | 1.3% | 7.7% | 9.1% | 11.8% | – | – | |
| – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 92.3% | 90.9% | 88.2% | 100.0% | 94.0% | |
| – | – | – | 13,150.3% | 971.7% | 932.2% | 1,095.9% | 299.7% | 732.1% | 888.8% | 1,428.5% | 985.2% | 212.2% | 1,322.4% | 2,039.6% | 80.3% | 513.5% | 701.7% | 726.9% | 753.1% | 14.1% | 338.9% | 259.3% | 233.3% | 238.3% | 324.0% | 289.7% | 256.3% | 300.0% | 75.2% | 294.9% | 256.3% | 388.5% | 435.7% | 86.9% | 542.3% | 366.7% | 717.6% | 275.6% | 424.8% | |
| – | – | – | 1,142.3% | 195.8% | 234.3% | 276.0% | 83.4% | 231.1% | 283.9% | 337.8% | 443.3% | 67.6% | 400.5% | 653.3% | 17.3% | 134.8% | 167.2% | 177.8% | 172.7% | 6.6% | 133.3% | 96.3% | 78.8% | 82.9% | 120.0% | 96.6% | 93.8% | 93.5% | 22.1% | 76.9% | 62.5% | 107.7% | 100.0% | 18.1% | 103.8% | 78.8% | 170.6% | 58.5% | 90.6% | |
| – | – | – | 14,292.6% | 1,167.5% | 1,166.5% | 1,371.9% | 383.0% | 963.3% | 1,172.7% | 1,766.3% | 1,428.5% | 279.8% | 1,722.9% | 2,692.9% | 97.6% | 648.2% | 868.9% | 904.7% | 925.9% | 20.7% | 472.2% | 355.6% | 312.1% | 321.2% | 444.0% | 386.2% | 350.0% | 393.5% | 111.0% | 371.8% | 318.8% | 496.2% | 535.7% | 105.0% | 638.5% | 436.4% | 876.5% | 334.1% | 509.4% | |
| – | – | – | -14,192.6% | -1,067.5% | -1,066.5% | -1,271.9% | -283.0% | -863.3% | -1,072.7% | -1,666.3% | -1,328.5% | -179.8% | -1,622.9% | -2,592.9% | 2.4% | -548.2% | -768.9% | -804.7% | -825.9% | 79.3% | -372.2% | -255.6% | -212.1% | -221.2% | -344.0% | -286.2% | -250.0% | -293.5% | -11.0% | -271.8% | -218.8% | -396.2% | -435.7% | -5.0% | -546.2% | -345.5% | -788.2% | -234.1% | -415.4% | |
| – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 315.1% | – | – | – | – | – | – | – | – | – | – | – | 0.1% | 2.2% | 3.7% | 1.6% | 1.7% | 4.0% | 0.0% | 3.1% | 6.5% | 0.7% | 0.0% | 2.1% | 7.7% | 3.6% | 1.3% | 11.5% | 42.4% | 17.6% | 7.3% | 19.7% | |
| – | – | – | -14,185.3% | -1,056.8% | -1,036.3% | -1,082.6% | -252.0% | -787.1% | -1,009.7% | -1,605.1% | -1,277.3% | -170.2% | -1,585.9% | -2,575.7% | 2.8% | -546.6% | -767.3% | -803.0% | -824.2% | 79.3% | -372.2% | -248.1% | -197.0% | -200.4% | -312.0% | -255.2% | -215.6% | -258.1% | -2.8% | -238.5% | -191.7% | -361.5% | -400.0% | -5.0% | -519.2% | -297.0% | -752.9% | -222.0% | -386.3% | |
| – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -157.4% | -87.7% | -84.7% | -71.7% | -8.8% | -27.5% | -7.5% | -0.4% | -19.2% | 4.6% | -1.1% | -1.1% | 0.5% | 5.6% | -8.7% | -13.6% | 0.0% | 8.0% | 3.4% | 6.3% | 3.2% | 0.7% | – | – | 3.8% | – | – | – | – | – | – | – | |
| – | – | – | -14,185.3% | -1,056.8% | -1,036.3% | -1,082.6% | -252.0% | -787.1% | -1,009.7% | -1,605.1% | -1,277.3% | -170.2% | -1,585.9% | -2,575.7% | 2.8% | -546.6% | -767.3% | -803.0% | -824.2% | 78.8% | -377.8% | -248.1% | -197.0% | -200.4% | -320.0% | -258.6% | -221.9% | -261.3% | -2.8% | -238.5% | -191.7% | -361.5% | -400.0% | -5.0% | -519.2% | -297.0% | -752.9% | -222.0% | -386.3% | |
| – | – | – | -13,743.6% | -1,006.2% | -1,000.2% | -1,198.7% | -260.3% | -802.6% | -1,018.3% | -1,615.8% | -1,277.9% | -171.0% | -1,566.5% | -2,539.3% | 4.0% | -529.1% | -758.8% | -794.3% | -814.0% | 80.2% | -366.7% | -237.0% | -190.9% | -194.4% | -300.0% | -248.3% | -209.4% | -248.4% | 4.8% | -233.3% | -185.4% | -342.3% | -385.7% | 2.5% | -500.0% | -245.5% | -723.5% | -207.3% | -358.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.